CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Short Interest Up 1,765.7% in July

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) was the recipient of a significant growth in short interest in the month of July. As of July 15th, there was short interest totaling 3,862 shares, a growth of 1,765.7% from the June 30th total of 207 shares. Based on an average daily trading volume, of 1,644 shares, the short-interest ratio is currently 2.3 days.

CSPC Pharmaceutical Group Stock Performance

CSPCY stock traded up C$0.06 during mid-day trading on Friday, reaching C$4.31. The company had a trading volume of 463 shares, compared to its average volume of 3,411. CSPC Pharmaceutical Group has a one year low of C$3.26 and a one year high of C$5.83. The stock’s 50-day simple moving average is C$3.78 and its two-hundred day simple moving average is C$4.40.

CSPC Pharmaceutical Group Company Profile

CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.

The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.